Advanced search
Publication Cover
Clinical Ophthalmology Volume 13, 2019 - Issue
Submit an article Journal homepage
108
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)

Faye HornerBirmingham and Midland Eye Centre, Birmingham, UK
,
Peck-Lin LipBirmingham and Midland Eye Centre, Birmingham, UKORCID Iconhttps://orcid.org/0000-0002-8404-7353
ORCID Icon,
Hannah ClarkBirmingham and Midland Eye Centre, Birmingham, UK
,
Randhir ChavanBirmingham and Midland Eye Centre, Birmingham, UKORCID Iconhttps://orcid.org/0000-0002-0280-4630
ORCID Icon,
Ambreen SarmadBirmingham and Midland Eye Centre, Birmingham, UK
&
Bushra MushtaqBirmingham and Midland Eye Centre, Birmingham, UKCorrespondence[email protected]
Pages 2461-2467 | Published online: 12 Dec 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Bianka Sobolewska, Muhammed Sabsabi & Focke Ziemssen. (2021) Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration. Clinical Ophthalmology 15, pages 4317-4326.
Read now
Hemal Mehta, Leah N Kim, Thibaud Mathis, Pardis Zalmay, Faruque Ghanchi, Winfried M Amoaku & Laurent Kodjikian. (2020) Trends in Real-World Neovascular AMD Treatment Outcomes in the UK. Clinical Ophthalmology 14, pages 3331-3342.
Read now

Articles from other publishers (7)

Levon M. Khachigian, Gerald Liew, Kelvin Y. C. Teo, Tien Y. Wong & Paul Mitchell. (2023) Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration. Journal of Translational Medicine 21:1.
Crossref
Jarret Charles & TRAN Thi Ha Chau. (2023) Five-year outcome of aflibercept intravitreal injection in naïve patients with neovascular age-related macular degeneration using a modified treat-and-extend regimen: Results from a prospective observational study. Taiwan Journal of Ophthalmology 0:0, pages 0.
Crossref
Thomas A. Ciulla, Rehan M. Hussain, Donna Taraborelli, John S. Pollack & David F. Williams. (2022) Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema. Ophthalmology Retina 6:9, pages 796-806.
Crossref
Daniele Veritti, Valentina Sarao, Valentina Soppelsa, Carla Danese, Jay Chhablani & Paolo Lanzetta. (2022) Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine 11:2, pages 325.
Crossref
Hyeon Cheol Roh, Sang Jin Kim, Se Woong Kang, Jun Soo Eun & Kyung Jun Choi. (2021) Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 260:1, pages 83-92.
Crossref
Nanna Jo Ferløv Baselius, Troels Brynskov, Mads Krüger Falk, Torben Lykke Sørensen & Yousif Subhi. (2021) Driving vision in patients with neovascular AMD in anti‐VEGF treatment. Acta Ophthalmologica 99:8.
Crossref
Ki Won Jin, Jae Hui Kim, Jun Young Park, Sang Jun Park, Kyu Hyung Park, Joo Yong Lee & Se Joon Woo. (2021) Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Scientific Reports 11:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.